Γ

SynBioBeta Speaker

Nicole Sonnert

Playground Global

Investment Associate

Nicole is an associate on the engineered biology investment team at Playground, where she identifies groundbreaking companies and helps support portfolio companies.Originally from Cambridge, MA, Nicole completed a dual degree engineering program at Mount Holyoke College and Dartmouth College, studying Biomathematics and Chemical Engineering. Afterward, she joined Adimab, L.L.C. as part of the antibody discovery team, contributing to partner campaigns including molecules that have reached the clinic.Nicole continued her academic journey at Yale University, earning a Ph.D. in Microbiology and a certificate in Physics and Engineering Biology as both a Gruber and NSF Graduate Research Fellow. Her work focused on mapping direct interactions between human proteins and bacteria from the microbiome, with her dissertation research published on the cover of Nature.Her interest in venture capital was sparked through a fellowship with Canaan Partners, and she served on the board of the Yale Biotech Club, where she directed venture capital programming.When not working, Nicole likes to spend time outside and making art.

Sessions Featuring

Nicole

This Year

NextGen BioLeaders Program

•

9:00 AM

-

10:00 AM

General

Bold VC Perspectives: How Biotech Gets Funded Today

A curated lineup of leading biotech VCs, each delivering a 5-minute rapid-fire briefing covering: fund focus, investment thesis, selection process, and their most actionable advice for fundraising in the current market

Featuring

Ivan Jaubert

SynBioBeta

Director of Entrepreneurship

Startup-ecosystem builder connecting founders, investors, and corporates.

Omri Amirav-Drory

NFX

General Partner

Scientist-founder VC: built Genome Compiler, now backs techbio.

Blair Willette

KdT Ventures

Investor

Nicole Sonnert

Playground Global

Investment Associate

Elliot Hershberg

Amplify Partners

Partner, Author

Driving the Century of Biology

Rohan Ganesh

Obvious Ventures

Partner

NextGen BioLeaders Program

•

9:00 AM

-

10:00 AM

General

Bold VC Perspectives: How Biotech Gets Funded Today

A curated lineup of leading biotech VCs, each delivering a 5-minute rapid-fire briefing covering: fund focus, investment thesis, selection process, and their most actionable advice for fundraising in the current market

Featuring

Ivan Jaubert

SynBioBeta

Director of Entrepreneurship

Startup-ecosystem builder connecting founders, investors, and corporates.

Omri Amirav-Drory

NFX

General Partner

Scientist-founder VC: built Genome Compiler, now backs techbio.

Blair Willette

KdT Ventures

Investor

Nicole Sonnert

Playground Global

Investment Associate

Elliot Hershberg

Amplify Partners

Partner, Author

Driving the Century of Biology

Rohan Ganesh

Obvious Ventures

Partner

TBD

Session lineup still growing

Featuring

Speaker Coming Soon

Fireside Chat

•

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Featuring

Speaker Coming Soon

Previous Speakers Include